Research and Development

The Research and Development team at Liquidia is responsible for the innovative design and advancement of therapeutic products targeting pulmonary arterial hypertension (PAH). This team conducts cutting-edge research, formulates drug candidates, and ensures quality control throughout the development process, ultimately aiming to address significant patient needs and bring effective solutions to market.